Status:
RECRUITING
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Lead Sponsor:
University of Ulm
Conditions:
Pancreas Adenocarcinoma
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Eligibility Criteria
Inclusion
- Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
- Age =\>18 years
- written informed consent
Exclusion
- papillary cancer
- neuroendocrine pancreatic tumors
Key Trial Info
Start Date :
October 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04099134
Start Date
October 10 2018
End Date
October 1 2029
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Ulm
Ulm, Germany